# Star Trek: Infection

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 3954580
- Developer: Played with Fire
- Released: 2026 · Genre: Action · List price: $29.99
- Deal grade: C (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $3.1k to $4.7k per month (mid $3.9k)
- Opportunity score: $3.9k/month at x1.00 dormancy multiplier
- Est. lifetime owners: 2.5k · Est. lifetime net revenue: $25.1k
- Review sentiment: 66% positive across 86 reviews (78 from Steam purchases)
- Review velocity: 15.6 reviews/month (6-month average)

## Why it's flagged

- Developer active, last post 3 months ago
- Last build shipped 3 months ago

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $7.1k |
| After VAT / sales tax (-13% blended) | $6.2k |
| After refunds (-9.5% median) | $5.6k |
| Net to developer (after Steam 30%) | $3.9k |

## Monthly review counts, oldest to newest (5 months)

44, 23, 6, 4, 1

## Markets by review language

- german: 14%
- english: 77%
- koreana: 1%
- russian: 1% (game NOT localized in this language)
- spanish: 4%
- french: 3%

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/3954580
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.